Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Natural compounds remain investigational for metabolic syndrome; leaves open efficacy pending prospective trials.
Metabolic syndrome (MetS) represents a cluster of metabolic abnormalities that include hypertension, central obesity, insulin resistance, and atherogenic dyslipidemia, and is strongly associated with an increased risk for developing diabetes and atherosclerotic and nonatherosclerotic cardiovascular disease (CVD). The pathogenesis of MetS involves both genetic and acquired factors that contribute to the final pathway of inflammation that leads to CVD. MetS has gained significant importance recently due to the exponential increase in obesity worldwide. Early diagnosis is important in order to employ lifestyle and risk factor modification. Here, we review the epidemiology and pathogenesis of MetS, the role of inflammation in MetS, and summarize existing natural therapies for MetS.
No takes yet. Share an insight, caveat, or question.
Rochlani et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: